Clinical trial registry record

Impact of "SI Kumbang" Gymnastic Exercise on Physical Performance and Immunity in the Elderly

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated December 24, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07300722
Last registry update
December 24, 2025
Status
Completed
Phase
Phase not reported
Sponsor
Umi Sjarqiah
Enrollment
66
Countries
Indonesia
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · PREVENTION · DOUBLE
Evidence population
Human clinical study registration
Participants
66
Population
FEMALE · 60 Years to 70 Years
Duration
2025-04-01 to 2025-09-30
Intervention
SI Kumbang gymnastic exercise; Bugar Lansia Gymnastic Exercise
Comparator
Bugar Lansia Gymnastic Exercise
Outcomes measured
Cardiorespiration endurance as Assessed by Six-Minute Walk Distance (6MWD) — From enrollment to the end of treatment at…; Strength muscle as Assessed by handgrip JAMAR — From enrollment to the end of treatment at 12 weeks.; Balance as Assessed by Short Physical Performance Battery (SPPB). — From enrollment to the end of treatment at 12 weeks; Physical activity as Assessed by Physical Activity Scale for the Elderly (PASE). — From enrollment to the end of treatm…; Immunity were inflammasome as Assessed by Caspase-1 and IL-18. — From enrollment to the end of treatment at 12 weeks.
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

exercise
Read the original source →Export JSON